The potential role in HIFU telehealth in the management of fibroid and adenomyosis after COVID-19 pandemic

Wu Shun Felix Wong, Yonghua Xu, Lian Zhang
In: World Journal of Advanced Research and Reviews · 2021 · vol. 9(2) , pp. 027–031 · doi:10.30574/wjarr.2021.9.2.0032 · W3127197293
article OA: hybrid CC0
📄 Open PDF View on OpenAlex View at publisher

Abstract

We come to realize the importance of “telehealth” during the current COVID-19 pandemic. Telehealth can be defined as providing health care, including preventive, diagnostic, and treatment services, by using information and communication technologies such as videoconferencing, electronic messaging, and telephone calls (1). With the rapid development of new treatment technology, communication, and fast speed networks, not only telehealth can provide medical services closer to home, but it also should provide the doctors and patients with additional benefits of safety, effectiveness, and satisfaction. HIFU is a new non-invasive ablation treatment for many solid tumors. This paper illustrates how the potential practice of HIFU ablation for fibroids can be modified to make it suitable for doctors in their HIFU training for treatment of fibroids and adenomyosis and for patients who need surgery using this new telehealth development.

My notes (saved in your browser only)

Condition tags

adenomyosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

References (10)

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK